Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Fever × Dermatologic × Clear all

Phase

Status

Completed 3 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 222 Carcinoma, Non-Small-Cell Lung 55 Carcinoma, Renal Cell 36 Skin Neoplasms 32 Squamous Cell Carcinoma of Head and Neck 31 Neoplasms 30 Uveal Melanoma 25 Colorectal Neoplasms 23 Lung Neoplasms 21 Neoplasm Metastasis 20 Ovarian Neoplasms 19 Carcinoma, Merkel Cell 19 Sarcoma 18 Breast Neoplasms 17 Stomach Neoplasms 16 Lymphoma, T-Cell, Cutaneous 16 Head and Neck Neoplasms 16 Pancreatic Neoplasms 13 Triple Negative Breast Neoplasms 12 Carcinoma, Basal Cell 12 Brain Neoplasms 12 Uterine Cervical Neoplasms 11 Mycosis Fungoides 11 Keratosis, Actinic 11 Esophageal Neoplasms 11 Carcinoma, Hepatocellular 11 Recurrence 10 Prostatic Neoplasms 10 Carcinoma, Squamous Cell 10 Urinary Bladder Neoplasms 9

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡